Neopharma

Neopharma is a globally recognized pharmaceutical manufacturing company headquartered in Abu Dhabi, United Arab Emirates. Founded in 2003, the company has grown from its initial investment outlay of USD 25 million into a multinational enterprise with 10 manufacturing facilities spread across three continents and regional offices in over 50 countries. Neopharma operates from the Industrial City of Abu Dhabi (ICAD) in Mussafah, strategically positioned near Delma Mall, and is dedicated to manufacturing high-quality, affordable medications for markets worldwide.

The company's vision is to create a comprehensive integrated healthcare enterprise that innovates and adapts to deliver the best in healthcare while upholding its core values of commitment, excellence, innovation, and integrity. Neopharma was founded by Dr. B.R. Shetty, who recognized the opportunity in pharmaceutical manufacturing and the importance of backward integration in the healthcare chain, leading to the establishment of Abu Dhabi's first state-of-the-art pharmaceutical plant. The company is also dedicated to the benevolent and wise leader, Father of the Nation, His Highness Sheikh Zayed Bin Sultan Al Nahyan.

Services from Neopharma

Neopharma delivers a vertically integrated pharmaceutical value chain encompassing research and development, active pharmaceutical ingredient (API) manufacturing, finished dose manufacturing, and marketing and distribution. This comprehensive approach allows the company to control quality at every stage from raw material synthesis to the final product reaching patients.

Research and Development

Driven by innovation, Neopharma places strong emphasis on research, particularly toward the development of processes and products that are patent non-infringing. The R&D division focuses on creating new formulations and improving existing therapeutic solutions across multiple disease categories.

API Manufacturing

Neopharma manufactures active pharmaceutical ingredients, the core biologically active components of medications. This capability ensures supply chain resilience and quality control from the earliest stage of drug production, supporting both Neopharma's own finished dose operations and supplying APIs to external partners globally.

Finished Dose Manufacturing

The company produces branded and generic formulations across a wide range of therapeutic segments. Neopharma's portfolio includes over 100 high-quality molecules covering anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental, and nutritionals.

Marketing and Distribution

Neopharma currently caters to over 50 international markets including the Middle East, Africa, CIS, Far East, and South East Asia. The company's distribution network ensures that its manufactured products reach healthcare providers and patients across these diverse regions efficiently and reliably.

Customer Reviews & Ratings

Neopharma holds a 4.5-star rating on Google Maps based on 38 reviews. According to customer reviews on Maps, recurring themes highlight the quality of the people and the company's standing in the UAE pharmaceutical landscape. One reviewer, sandhya kk, a Local Guide, described Neopharma as the "Best pharma company in the UAE." Another reviewer, Gloderose Garcia, expressed appreciation for the workplace environment, noting "wonderful people" and sharing a sense of fondness for the organization. A review from محمد الباشا simply praised the company with an enthusiastic endorsement. The consistent positive sentiment across reviews reflects Neopharma's reputation as a respected employer and pharmaceutical manufacturer in the region.

Neopharma in Abu Dhabi

Neopharma's main manufacturing facility is located at Plot A-1 89-95, Industrial City of Abu Dhabi (ICAD), Mussafah, Abu Dhabi, United Arab Emirates. The ICAD area is a designated industrial zone in Abu Dhabi that houses numerous manufacturing and industrial operations. The facility's main gate is situated near Delma Mall, a well-known commercial landmark in the Mussafah area, making it easily identifiable for visitors and business partners. Neopharma also operates a subsidiary, Neopharma Japan Co. Ltd, located in Iidabashi Grand Bloom, Chiyoda-ku, Tokyo, extending its global footprint into the Japanese market. The company's operating hours are Monday through Friday, 08:30 to 18:30, as indicated by Google Maps data.

What Sets Neopharma Apart

Several factors distinguish Neopharma in the global pharmaceutical manufacturing landscape. The company's vertically integrated model — spanning from API synthesis through finished dose production to marketing and distribution — provides end-to-end quality oversight and supply chain control that few regional competitors can match. With 10 manufacturing facilities across three continents, Neopharma has built a truly global production network while maintaining its roots in Abu Dhabi. The company holds MOH Approval under License number WQ23097-0015662608151147-11-08-2016, confirming its compliance with UAE health authority regulations. Neopharma's portfolio of over 100 high-quality molecules across 12 therapeutic segments offers breadth that serves diverse healthcare needs across its 50+ international markets. The company's commitment to developing patent non-infringing processes and products demonstrates its focus on innovation within established therapeutic frameworks, balancing accessibility with intellectual property respect. Neopharma also actively warns the public about employment scams, maintaining transparency and protecting job seekers from fraudulent entities falsely claiming to represent the company — a practice that underscores its corporate integrity.

Common Questions

What therapeutic areas does Neopharma cover?

Neopharma's portfolio spans anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental, and nutritionals — covering over 100 high-quality molecules across these therapeutic segments.

How many countries does Neopharma serve?

Neopharma currently caters to over 50 international markets, including the Middle East, Africa, CIS, Far East, and South East Asia regions.

Does Neopharma manufacture its own APIs?

Yes, Neopharma manufactures active pharmaceutical ingredients (APIs) as part of its vertically integrated pharmaceutical operations, alongside finished dose manufacturing and distribution.

How can I contact Neopharma for business partnerships?

For general enquiries, contact neopharma@neopharma.com. For business development and partnership discussions, reach out to bd@neopharma.com. You can also call +971-025501000 or visit their facility at ICAD, Mussafah, Abu Dhabi.

What are Neopharma's operating hours?

According to Google Maps, Neopharma operates Monday through Friday from 08:30 to 18:30. The facility is closed on weekends.

Does Neopharma charge fees for job applications?

No. Neopharma has issued an official notice stating that the company does not charge any fee or request any payment at any stage of the recruitment process, including application, interview, selection, or training. All genuine job offers come directly from Neopharma's official HR department through verified communication channels.

Does Neopharma have international subsidiaries?

Yes, Neopharma operates Neopharma Japan Co. Ltd as a subsidiary, located in Iidabashi Grand Bloom, Chiyoda-ku, Tokyo, with contact available at +0120-392-750 and www.neopharmajp.co.jp.

Whether you are a healthcare provider seeking reliable pharmaceutical supply, a business partner exploring collaboration opportunities, or a professional considering a career in pharmaceutical manufacturing, Neopharma's integrated capabilities and global reach make it a significant player in the industry. Compare pharmaceutical manufacturers on Ilistify to find the right partner for your needs.